Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fe Tubau

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|July 8, 2025
Amoxicillin-non-susceptible <i>Streptococcus pneumoniae</i> causing invasive pneumonia: serotypes, clones, and clinical impactJordi Càmara, Inmaculada Grau, Aida González-Díaz, et al.
BMC Microbiology|September 4, 2015
Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospitalMeritxell Cubero, Guillermo Cuervo, M Ángeles Dominguez, et al.
Microorganisms|November 27, 2021
Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate VaccinesLucía Fernández-Delgado, Jordi Càmara, Aida González-Díaz, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter studyGabriel Cabot, Alain A Ocampo-Sosa, Fe Tubau, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2025
First report of a DIM-1-producing <i>Pseudomonas aeruginosa</i> in Spain: genomic characterization and resistance determinantsIrene Cadenas-Jiménez, Aida González-Díaz, Dàmaris Berbel, et al.
Infection and Drug Resistance|September 15, 2018
Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016Hisashi Shoji, Daniel A Vázquez-Sánchez, Aida Gonzalez-Diaz, et al.
Journal of Clinical Pharmacy and Therapeutics|March 7, 2022
Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experienceMar Ronda, Sandra Pérez-Recio, Mònica González Laguna, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 2017
Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasmaRaül Rigo-Bonnin, Alba Ribera, Ariadna Arbiol-Roca, et al.
The Journal of Antimicrobial Chemotherapy|December 23, 2017
Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infectionEvelyn Shaw, Alexander Rombauts, Fe Tubau, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2012
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clonesGabriel Cabot, Alain A Ocampo-Sosa, M Angeles Domínguez, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|July 8, 2025
Amoxicillin-non-susceptible <i>Streptococcus pneumoniae</i> causing invasive pneumonia: serotypes, clones, and clinical impactJordi Càmara, Inmaculada Grau, Aida González-Díaz, et al.
BMC Microbiology|September 4, 2015
Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospitalMeritxell Cubero, Guillermo Cuervo, M Ángeles Dominguez, et al.
Microorganisms|November 27, 2021
Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate VaccinesLucía Fernández-Delgado, Jordi Càmara, Aida González-Díaz, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2011
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter studyGabriel Cabot, Alain A Ocampo-Sosa, Fe Tubau, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2025
First report of a DIM-1-producing <i>Pseudomonas aeruginosa</i> in Spain: genomic characterization and resistance determinantsIrene Cadenas-Jiménez, Aida González-Díaz, Dàmaris Berbel, et al.
Infection and Drug Resistance|September 15, 2018
Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016Hisashi Shoji, Daniel A Vázquez-Sánchez, Aida Gonzalez-Diaz, et al.
Journal of Clinical Pharmacy and Therapeutics|March 7, 2022
Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experienceMar Ronda, Sandra Pérez-Recio, Mònica González Laguna, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 2017
Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasmaRaül Rigo-Bonnin, Alba Ribera, Ariadna Arbiol-Roca, et al.
The Journal of Antimicrobial Chemotherapy|December 23, 2017
Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infectionEvelyn Shaw, Alexander Rombauts, Fe Tubau, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2012
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clonesGabriel Cabot, Alain A Ocampo-Sosa, M Angeles Domínguez, et al.
Pageof 13